MNV
Market News Video
MNV MNV The 10 Most Popular Large-Caps in ETFs
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Krystal Biotech Reaches Analyst Target Price
Tuesday, May 23, 7:25 AM ET, by Market News Video Staff

In recent trading, shares of Krystal Biotech Inc (KRYS) have crossed above the average analyst ...

Commit To Buy Krystal Biotech At $80, Earn 7.4% Using Options
Wednesday, August 9, 2:42 PM ET, by Market News Video Staff

Investors eyeing a purchase of Krystal Biotech Inc (KRYS) stock, but tentative about paying the ...

Sum Up The Parts: FTXH Could Be Worth $32
Thursday, October 12, 7:45 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Notable Wednesday Option Activity: KRYS, COOP, FCFS
Wednesday, October 25, 3:21 PM ET, by Market News Video Staff

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume ...

Commit To Purchase Krystal Biotech At $75, Earn 9.7% Using Options
Tuesday, November 7, 1:16 PM ET, by Market News Video Staff

Investors eyeing a purchase of Krystal Biotech Inc (KRYS) shares, but tentative about paying the ...

Investors Bag KRYS 8.2% Lower Than Its Secondary Stock Offering

By Market News Video Staff, Thursday, December 2, 10:05 AM ET
Play Video: The Importance of ETFs


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Email EnvelopeFree Email Alerts By Stock:
Get Dividend Alerts
Get SEC Filing Alerts

Looking back to 2 days ago, Krystal Biotech Inc (NASDAQ:KRYS) priced a 2,666,667 share secondary stock offering at $75.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time. In trading on Thursday, bargain hunters could buy shares of KRYS and achieve a cost basis 8.2% cheaper than those buyers, with shares changing hands as low as $68.82 per share.

Secondaries can often present buying opportunities for bullish investors interested in purchasing shares, because the sudden extra supply of stock tends to require that the offering be priced at an attractive discount to where the stock had previously been trading before the offering announcement. At last check, Krystal Biotech Inc shares are currently trading up about 2.2% on the day. The chart below shows the one year performance of KRYS shares, versus its 200 day moving average:

Krystal Biotech Inc Chart

Looking at the chart above, KRYS's low point in its 52 week range is $38.8563 per share, with $102.99 as the 52 week high point — that compares with a last trade of $71.09.


Free Report: Top 7%+ Dividends (paid monthly)


This Article's Word Cloud:   Biotech   Buyers   Dividends   Free   KRYS   Krystal   Looking   Offerings   Recent   Report   Secondaries   Secondary   Start   Stock   Thursday   about   above   achieve   announcement   attractive   average   back   bargain   basis   because   been   before   below   bullish   buyers   buying   changing   chart   cheaper   check   company   compares   considerable   investment   last   offering   point   priced   share   shares   stock   that   trading   week   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Portfolio Channel Stock Market Definitions
MNV

Investors Bag KRYS 8.2% Lower Than Its Secondary Stock Offering | Market News Video | Copyright © 2008 - 2024, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.

X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.